Leukemia Clinical Trials

Showing 3341-3360 of 10,987 trials

Enrolling By InvitationEARLY Phase 1

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

NCT06747832

This is a clinical study on the use of iNK cells for the treatment of small cell lung cancer.

Small Cell Lung Cancer

Guangzhou Ruixin Biotechnological Co., LTD10 participantsStarted Dec 2024

Weifang, Shandong Province, China., China

Active Not RecruitingNA

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

NCT05142618

This study aims to evaluate the potential role of physical therapy in improving outcomes after ventral hernia repair.

Ventral HerniaHerniaHerniorrhaphy+3 more

Ohio State University138 participantsStarted Apr 2022

Columbus, Ohio, United States

COMPLETED

Real-World Immuno-Radiotherapy for Advanced NSCLC

NCT06747026

The optimal combination strategy for radiotherapy combined with immunotherapy (iRT) in advanced non-small-cell lung cancer (NSCLC) remains unclear, and there is a lack of real-world data to validate its efficacy. The objective of this study is to confirm the survival benefits of iRT in advanced NSCLC and to identify the optimal combination strategy for its use.

Lung Cancer Non-Small Cell Cancer (NSCLC)

Fengming Kong338 participantsStarted Jan 2015

Hong Kong, HongKong, Hong Kong

INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer

Pilot Trial of Abdominal Core Rehabilitation To Improve Outcomes After Ventral Hernia Repair

Real-World Immuno-Radiotherapy for Advanced NSCLC

Related Searches

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Durvalumab (MEDI4736) and Radiosurgery (fSRT Vs. PULSAR) for the Treatment of Non-Small Cell Lung Cancer Brain Metastases

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study

Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer

The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis Population

Virtual Reality Fall Education for Caregivers

Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

VHAG in Treating R/R T-ALL/LBL

Microbial Study of Sublingual Immunotherapy Tablets in Patients With Allergic Rhinitis

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

A Phase Ib/II Multicenter Open-label Study of Bemcentinib (BGB324) in Patients With AML or MDS

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC

PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1